It’s no secret that we are in the midst of an opioid crisis. Late 1990s, healthcare providers prescribed opioids at increasing rates, based on pharmaceutical companies’ belief that patients would not become addicted to the pain relievers.
Unfortunately, the increased prescription numbers led to a widespread misuse of the products; both prescriptions and non-prescription opioids were being used and sold for its addictive tendency (HHS.gov).
- Access: Better prevention, treatment, and recovery services
- Data: Support improved data metrics for understanding the crisis
- Pain: Better pain management and information to promote healthy methods of pain management
- Overdoses: Improved availability of lifesaving overdose-reversing drugs
- Research: Improved understanding on pain and addiction
AvKARE offers Buprenorphine-Naloxone to healthcare facilities
AvKARE offers Buprenorphine-Naloxone, used to treat opioid dependence and addiction. It helps prevent withdrawal symptoms from stopping other opioids and blocks the effect of opioids. The combination of these drugs is used to prevent abuse and misuse, and is part of a complete treatment program for drug abuse.
For healthcare facilities and pharmacies, AvKARE offers unit dose of Buprenorphine-Naloxone in 50-count sizes, a packaging strategy that promotes ease of cash flow for hospitals and helps reduce the liability of incorrect dosing of a patient.
The product is offered to acute care facilities through all major GPOs and Wholesalers, with consistent supply of product to meet your needs. AvKARE also offers two separate strengths – 2mg/0.5mg and 8mg/2mg. AvKARE’s product also does not leave a bad aftertaste to promote consistent therapeutic practices. We are dedicated to supporting the 5-Point Strategy and the more consistent the patient can use the product, the more effective the drug will be in reducing addiction.
For More Information
If you are interested in AvKARE’s product offerings, contact us at email@example.com or email me, Kerry Dilley, at firstname.lastname@example.org